258 related articles for article (PubMed ID: 23813921)
1. Ofatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma.
Ketterl TG; Messinger YH; Niess DR; Gilles E; Engel WK; Perkins JL
Pediatr Blood Cancer; 2013 Dec; 60(12):E163-5. PubMed ID: 23813921
[TBL] [Abstract][Full Text] [Related]
2. Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus.
Pranzatelli MR; Tate ED; Shenoy S; Travelstead AL
Pediatr Blood Cancer; 2012 Jun; 58(6):988-91. PubMed ID: 21618414
[TBL] [Abstract][Full Text] [Related]
3. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
[TBL] [Abstract][Full Text] [Related]
4. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus.
Bell J; Moran C; Blatt J
Pediatr Blood Cancer; 2008 Feb; 50(2):370-1. PubMed ID: 16652344
[TBL] [Abstract][Full Text] [Related]
5. Antineuronal Nuclear Autoantibody Type 1/Anti-Hu-Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua: Case Report and Literature Review.
Sweeney M; Sweney M; Soldán MM; Clardy SL
Pediatr Neurol; 2016 Dec; 65():86-89. PubMed ID: 27707529
[TBL] [Abstract][Full Text] [Related]
6. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
7. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
8. Opsoclonus-myoclonus in children associated or not with neuroblastoma.
Krug P; Schleiermacher G; Michon J; Valteau-Couanet D; Brisse H; Peuchmaur M; Sarnacki S; Martelli H; Desguerre I; Tardieu M
Eur J Paediatr Neurol; 2010 Sep; 14(5):400-9. PubMed ID: 20110181
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
Gupta A; Kundal R; Pandey M
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
Burke MJ; Cohn SL
Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
de Alarcon PA; Matthay KK; London WB; Naranjo A; Tenney SC; Panzer JA; Hogarty MD; Park JR; Maris JM; Cohn SL
Lancet Child Adolesc Health; 2018 Jan; 2(1):25-34. PubMed ID: 29376112
[TBL] [Abstract][Full Text] [Related]
12. The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours-Single-Centre Experience and Literature Review.
Mizia-Malarz A; Stolpa W; Sobol-Milejska G
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823831
[No Abstract] [Full Text] [Related]
13. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
Chang BH; Koch T; Hopkins K; Malempati S
Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
[TBL] [Abstract][Full Text] [Related]
14. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
[TBL] [Abstract][Full Text] [Related]
15. Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
Toyoshima D; Morisada N; Takami Y; Kidokoro H; Nishiyama M; Nakagawa T; Ninchoji T; Nozu K; Takeshima Y; Takada S; Nishio H; Iijima K
Brain Dev; 2016 Mar; 38(3):346-9. PubMed ID: 26375512
[TBL] [Abstract][Full Text] [Related]
16. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
[TBL] [Abstract][Full Text] [Related]
17. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
Blaes F; Pike MG; Lang B
J Neuroimmunol; 2008 Sep; 201-202():221-6. PubMed ID: 18687475
[TBL] [Abstract][Full Text] [Related]
19. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome.
Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F
J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043
[TBL] [Abstract][Full Text] [Related]
20. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Beck S; Fühlhuber V; Krasenbrink I; Tschernatsch M; Kneifel N; Kirsten A; Jaeger C; Kaps M; Preissner KT; Lang B; Rostasy K; Blaes F
J Neuroimmunol; 2007 Apr; 185(1-2):145-9. PubMed ID: 17324472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]